Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Bladder Cancer TAS2R38 Expression on Chemotherapy-Induced Bitter Taste

NCT04567719 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT04567719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04567719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Bladder Cancer TAS2R38 Expression on Chemotherapy-Induced Bitter Taste
Lead sponsor
University of Kansas Medical Center
Phase
Observational
Overall status
Unknown status
Start date
March 3, 2020
Completion date
December 31, 2024
Enrollment
9 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer